| scholarly article | Q13442814 |
| P2093 | author name string | D C Rockey | |
| J J Chung | |||
| P2860 | cites work | Endothelin versatility | Q59095702 |
| Endothelin | Q67711713 | ||
| Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study | Q67961026 | ||
| Endothelin, a potent peptide agonist in the liver | Q68556300 | ||
| Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells | Q69737804 | ||
| Endothelin stimulates PDGF secretion in cultured human mesangial cells | Q70239383 | ||
| Purified Rat Liver Fat-Storing Cells in Culture Divide and Contain Collagen | Q70354518 | ||
| Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis | Q72221719 | ||
| Endothelin-1 immunoreactivity and mRNA in the transplanted human heart | Q72266502 | ||
| Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat | Q72738427 | ||
| Coupling of endothelin B receptors to the calcium pump and phospholipase C via Gs and Gq in rat liver | Q72739848 | ||
| Endothelin receptors in cultured adult rat cardiac fibroblasts | Q72785732 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter | Q27861016 | ||
| Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons | Q28243225 | ||
| Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis | Q28568136 | ||
| A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
| Advantages of Sirius Red staining for quantitative morphometric collagen measurements in lungs | Q34057850 | ||
| Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis | Q34252968 | ||
| Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo | Q34263631 | ||
| SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist | Q35679506 | ||
| Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway | Q35749916 | ||
| Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. | Q36583579 | ||
| Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. | Q37821791 | ||
| Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src | Q38319444 | ||
| Endothelin association with the cultured rat Kupffer cell: Characterization and regulation | Q38574021 | ||
| Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo | Q40305319 | ||
| Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1 beta | Q40343929 | ||
| Growth regulatory properties of endothelins | Q40902404 | ||
| Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies | Q40911465 | ||
| Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome | Q41100847 | ||
| Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture | Q41122442 | ||
| Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes | Q41907063 | ||
| The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis | Q42051784 | ||
| Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat | Q42119681 | ||
| Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist | Q42283587 | ||
| Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction | Q44160313 | ||
| Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix | Q46068321 | ||
| Characterization of endothelin receptors mediating rat hepatic stellate cell contraction | Q46467173 | ||
| Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. | Q54336361 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| wound healing | Q1509074 | ||
| P304 | page(s) | 1381-1388 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing | |
| P478 | volume | 98 |
| Q33954012 | A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis |
| Q35071055 | Adiponectin regulation of stellate cell activation via PPARγ-dependent and -independent mechanisms |
| Q37353099 | Advances in antifibrotic therapy |
| Q44853553 | Angiogenic properties of myofibroblasts isolated from normal human skin wounds |
| Q51034373 | Angiotensin II induces endothelin-1 expression in human hepatic stellate cells. |
| Q41986030 | Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model |
| Q36036857 | Antifibrotic therapy in chronic liver disease |
| Q57288769 | Antifibrotics in liver disease: are we getting closer to clinical use? |
| Q39655616 | Apelin Mediates the Induction of Profibrogenic Genes in Human Hepatic Stellate Cells |
| Q34118689 | Association of age-dependent liver injury and fibrosis with immune cell populations |
| Q37780253 | At the heart of tissue: endothelin system and end-organ damage |
| Q44323041 | Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. |
| Q37482884 | Cardiac myofibroblasts isolated from the site of myocardial infarction express endothelin de novo |
| Q35940948 | Cell and molecular regulation of endothelin-1 production during hepatic wound healing |
| Q42450671 | Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells |
| Q33840143 | Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription. |
| Q37317654 | Current and future anti-fibrotic therapies for chronic liver disease |
| Q36855682 | Divergent transforming growth factor-beta signaling in hepatic stellate cells after liver injury: functional effects on ECE-1 regulation |
| Q43994820 | Effects of endothelins on hepatic stellate cell synthesis of endothelin-1 during hepatic wound healing |
| Q47720284 | Endothelin 1 aggravates acute liver injury in perfused livers of rats after treatment with D-galactosamine |
| Q90522780 | Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy |
| Q37855219 | Endothelin and hepatic wound healing |
| Q30488861 | Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease |
| Q35596657 | Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats. |
| Q48057773 | Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats. |
| Q42494782 | Endothelin stimulates transforming growth factor-beta1 and collagen synthesis in stellate cells from control but not cirrhotic rat liver |
| Q39095075 | Endothelin-1 enhances fibrogenic gene expression, but does not promote DNA synthesis or apoptosis in hepatic stellate cells |
| Q54085349 | Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension. |
| Q40902696 | Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. |
| Q35621321 | Endothelin-1 stimulates contraction and migration of rat pancreatic stellate cells |
| Q30883488 | Endothelin-1 suppresses plasma membrane Ca++-ATPase, concomitant with contraction of hepatic sinusoidal endothelial fenestrae |
| Q46872431 | Endothelin-1, an ulcer inducer, promotes gastric ulcer healing via mobilizing gastric myofibroblasts and stimulates production of stroma-derived factors |
| Q73246072 | Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes--an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis |
| Q42455012 | Fibronectin stimulates endothelin-1 synthesis in rat hepatic myofibroblasts via a Src/ERK-regulated signaling pathway |
| Q34874953 | Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology |
| Q46454209 | Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat. |
| Q34269628 | Hepatic fibrosis. Pathogenesis and principles of therapy |
| Q99616727 | Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension |
| Q29616840 | Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver |
| Q26771518 | Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step |
| Q38211494 | Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature |
| Q54782119 | Increased expression of endothelin receptors in human cirrhosis--relationship with splanchnic hemodynamics. |
| Q41773351 | Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis |
| Q41857741 | Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis |
| Q43854041 | Influence of indomethacin on effects of endothelin-1 on guinea pig isolated rings of common bile duct and sphincter of Oddi |
| Q41845585 | Kindlin-2 could influence breast nodule elasticity and improve lymph node metastasis in invasive breast cancer. |
| Q36923228 | Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice |
| Q38980893 | Liver Fibrosis Reversion After Suppression of Hepatitis B Virus |
| Q35068035 | Liver fibrosis -- from bench to bedside |
| Q54590323 | Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. |
| Q33888050 | Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases. |
| Q37401080 | Murine fetal skin-derived cultured mast cells: a useful tool for discovering functions of skin mast cells |
| Q34173695 | Myofibroblasts: molecular crossdressers. |
| Q27692541 | Myofibroblasts: trust your heart and let fate decide. |
| Q35962193 | New concepts in the pathogenesis of portal hypertension: hepatic wounding and stellate cell contractility |
| Q40591380 | PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation |
| Q42488577 | PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury |
| Q35849962 | Pancreatic secretory trypsin inhibitor I reduces the severity of chronic pancreatitis in mice overexpressing interleukin-1β in the pancreas. |
| Q35156869 | Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor |
| Q28573556 | Preproendothelin-1 expression is negatively regulated by IFNγ during hepatic stellate cell activation |
| Q46255340 | Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice |
| Q35045421 | Prevention of cultured rat stellate cell transformation and endothelin-B receptor upregulation by retinoic acid |
| Q39617664 | Protection against chronic pancreatitis and pancreatic fibrosis in mice overexpressing pancreatic secretory trypsin inhibitor |
| Q57570922 | Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice |
| Q34374906 | Regional and systemic hemodynamic disturbances in cirrhosis |
| Q77897001 | Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing |
| Q52969695 | Regulation of the hepatic endothelin system in advanced biliary fibrosis in rats. |
| Q35309176 | Regulator of G-protein signaling-5 is a marker of hepatic stellate cells and expression mediates response to liver injury |
| Q92287804 | Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH |
| Q30000071 | Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data |
| Q34615080 | Role of endothelin-1 in acute lung injury. |
| Q35168394 | Role of endothelins in animal models of hypertension: focus on cardiovascular protection. |
| Q34584808 | Role of myofibroblasts at the invasion front |
| Q35170428 | Role of tissue stroma in cancer cell invasion |
| Q36254969 | Sarcomeric gene expression and contractility in myofibroblasts |
| Q40891185 | Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. |
| Q77451249 | Studies on the endothelin-1-induced contraction of rat granulation tissue pouch mediated by myofibroblasts |
| Q36334912 | Targeting the stromal fibroblasts: a novel approach to melanoma therapy |
| Q45895068 | Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model |
| Q34170449 | The cell and molecular biology of hepatic fibrogenesis. Clinical and therapeutic implications |
| Q46592660 | The effects of endothelin receptor blockade by bosentan on the healing of a bowel anastomosis in an experimental Crohn's disease model. |
| Q34118683 | The function of integrin-linked kinase in normal and activated stellate cells: implications for fibrogenesis in wound healing |
| Q36067020 | The role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights. |
| Q53621019 | The role of integrin-linked kinase in liver wound healing. |
| Q80148483 | The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis |
| Q46449134 | Therapeutic effects and possible mechanisms of a snake venom preparation in the fibrotic rat liver |
| Q38073028 | Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies |
| Q35046541 | Treatment of hepatic fibrosis: almost there |
| Q34093107 | Tumor necrosis factor α stimulates endothelin-1 synthesis in rat hepatic stellate cells in hepatic wound healing through a novel IKK/JNK pathway |
| Q36020916 | Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches |
| Q73838465 | Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy |
Search more.